 |
| Global Intragastric Balloons Market - Strategic Asessment and Forecast Till 2021 |
Intragastric balloons are the saline-filled silicone balloons
placed in the stomach for a span of months and limits intake of food by giving
the feeling of satiety. These balloons permit patients to sense fullness,
controls hunger, delays gastric emptying by altering gut hormones and peptides
thus reducing food intake ultimately.
Today,
intragastric balloons can be used as treatment for obesity as a pre-emptive
therapy, a metabolic therapy, or a primary therapy. Endoscopic procedures under
mild sedation are used to place one or more intragastric balloons in the
stomach in an outpatient setting. These balloons not only help in weight loss
but also helps in recovering the metabolic disorders. The intragastric balloons
are widely used because of its advantages of easy implantation, cost
effectiveness and less risk. There are various advantages offered by
intragastric balloons such as improved metabolism, alterations in
gastrointestinal hormones, low price, and short hospital stay.
The
worldwide intragastric balloons market is expected to reach approx. US$198.56
million by 2021, growing at a CAGR of 7.01% during the forecast period
2015-2021.
Factors such as presence of a
large obese population, change in lifestyle, need to
reduce hospital stay, short
recovery time, and availability of low-priced intragastric
balloons are driving the growth
of the global intragastric balloons market.
Also, growing opportunities in
the obesity market in the US are likely to serve as
high growth revenue pockets for
players operating in the market. In 2015, the US
spent US$10,000 per person on
healthcare annually; this figure is almost two-and a-
half times that of countries in
the Organization for Economic Cooperation and
Development (OECD), and 50%
higher than the next-highest spending countries,
namely, Switzerland and Norway. A
large portion of the US healthcare expenditure
is spent on programs related to
chronic diseases such as obesity. The growing
adoption of intragastric balloons
is expected to drive in the US to manage obesity.
However, limitations and adverse
events of intragastric balloons are likely to limit
the adoption of this technology. In
terms of geography, EMEA accounted for a major share of the market in 2015. This
can be attributed to increased consumption of fast food in these regions, reduced
physical activities, and Europe being the old market to use intragastric
ballooning technique.
Apollo Endosurgery, ReShape
Medical, Helioscopie, Allurion Technologies, Obalon
Therapeutics are among the
leading players in the market. After the USFDA approval, ORBERA (Apollo
Endosurgery Inc.) and ReShape Duo (ReShape Medical Inc.) in 2015, the
intragastric balloons re-entered the US market. Also, in March 2015, Obalon
Therapeutics Inc. initiated patient enrolment in a multi-center US pivotal
trial of the Obalon balloon post which Obalon would be approved for sale in the
US. In addition, in late 2015, Elipse by Allurion Technologies received
European Union (EU) CE mark approval and is available in
the UK, Italy, and France. Fengh
Medical, MEDSIL, Phagia Technologies, Silimed, Endalis, Tulip Medical Products,
LIFE PARTNERS EUROPE, BARAnova Therapeutics, Districlass Medical, and Shandong
Institute of Medical Instruments are other players in the market.
About Beige Market Intelligence
Beige Market
Intelligence is a provider of competitive business intelligence, working across
various industry verticals. Our expertise and knowledge ensures that the market
analysis Beige provides is comprehensive, detailed and complete. The analysis
helps our client organizations become aware and to make educated decisions, as
far as investing or devising a marketing strategy is concerned. The actionable
insights delivered through our market research provide a comprehensive market
analysis for every level of market segmentation in an industry.
Our team of
experts ensure the analysis you receive is not just analyzed and presented, but
can also be customized based on the client’s requirement. Our deliverables
guarantee our current global client base do not look beyond Beige when it comes
to competitive intelligence.
Beige has an
employee base present across the globe. Our analysts come with numerous years
of industry experience, which ensures we not only understand our clients but
deliver high quality reports as well.
Mail:
contactus@beigemarketintelligence.com
US: +1 347 903
9949
UK: +44 20 323
99499
APAC: +91 99 012
75473
No comments:
Post a Comment